RSSearch Patient Registry for SRS/SBRT Treatments
This study, called the RSSearch Patient Registry, is collecting information long-term about how Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) are used and how well they work. These are types of radiation therapy. The registry aims to understand the most effective ways to use SRS/SBRT for conditions like tumors (neoplasms), brain arteriovenous malformations (a tangle of abnormal blood vessels), and trigeminal neuralgia (a chronic pain condition). Researchers will track patient characteristics, treatment plans, and outcomes like overall survival for up to 5 years. You can join if you have a condition that can be treated with SRS/SBRT and are willing to sign an informed consent form. This is an observational study, meaning researchers are watching and recording information, not testing a new treatment. The study is actively enrolling a large number of participants.
- Study design
- This is an observational study designed to collect information from up to 50,000 participants. It is not testing a new treatment but rather observing current practices and outcomes.
- What's involved
- You would need to sign an Informed Consent Document or verbally agree to participate. The study will record information about your treatment and outcomes.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track outcomes, such as overall survival, for up to 5 years after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
At a glance
Conditions
Where it's being run
13 sites across 9 statesStudy leadership
- Anand Mahadevan, MD · STUDY_DIRECTOR · The Radiosurgery Society
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Overall survivalUp to 5 years
Survival from time of treatment to death